Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022
Introduction: parvovirus B19 (B19V) infection during pregnancy can be transmitted to the fetus and cause serious complications such as fetal hydrops and stillbirth. The preexistence of specific IgG prevents vertical transmission. Seroprevalence in fertile age is variable (50-70%) and depends on the...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2024
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/44771 |
| Aporte de: |
| id |
I10-R327-article-44771 |
|---|---|
| record_format |
ojs |
| institution |
Universidad Nacional de Córdoba |
| institution_str |
I-10 |
| repository_str |
R-327 |
| container_title_str |
Revista de la Facultad de Ciencias Médicas de Córdoba |
| language |
Español |
| format |
Artículo revista |
| topic |
human parvovirus b19 pregnancy seroprevalence fetal hydrops anemia parvovirus B19 gestación seroprevalencia hidropesía fetal anemia parvovírus B19 gravidez soroprevalência anemia hidropisia fetal |
| spellingShingle |
human parvovirus b19 pregnancy seroprevalence fetal hydrops anemia parvovirus B19 gestación seroprevalencia hidropesía fetal anemia parvovírus B19 gravidez soroprevalência anemia hidropisia fetal Dicuatro, Néstor Colazo Salbetti, María Belén Boggio, Gabriel Amilcar Ortiz, Emilia Pedranti, Mauro Olivera, Nicolás Lionel Lucchini, Héctor González, Alicia Resino, Carlos Moreno, Laura Adamo, Maria Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| topic_facet |
human parvovirus b19 pregnancy seroprevalence fetal hydrops anemia parvovirus B19 gestación seroprevalencia hidropesía fetal anemia parvovírus B19 gravidez soroprevalência anemia hidropisia fetal |
| author |
Dicuatro, Néstor Colazo Salbetti, María Belén Boggio, Gabriel Amilcar Ortiz, Emilia Pedranti, Mauro Olivera, Nicolás Lionel Lucchini, Héctor González, Alicia Resino, Carlos Moreno, Laura Adamo, Maria |
| author_facet |
Dicuatro, Néstor Colazo Salbetti, María Belén Boggio, Gabriel Amilcar Ortiz, Emilia Pedranti, Mauro Olivera, Nicolás Lionel Lucchini, Héctor González, Alicia Resino, Carlos Moreno, Laura Adamo, Maria |
| author_sort |
Dicuatro, Néstor |
| title |
Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| title_short |
Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| title_full |
Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| title_fullStr |
Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| title_full_unstemmed |
Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 |
| title_sort |
seroprevalence and infection by human parvovirus b19 in pregnant women from córdoba, argentina, 2021-2022 |
| description |
Introduction: parvovirus B19 (B19V) infection during pregnancy can be transmitted to the fetus and cause serious complications such as fetal hydrops and stillbirth. The preexistence of specific IgG prevents vertical transmission. Seroprevalence in fertile age is variable (50-70%) and depends on the region/viral circulation, in addition to factors such as maternal age and frequent exposure to children. Objectives: to determine seroprevalence for B19V in pregnant women at Hospital Universitario de Maternidad y Neonatología (HUMN), analyze its association with predictive factors and describe cases of B19V infection. Methods: observational, cross-sectional study. Patients treated at HUMN during 2021-2022 were included and compatible demographic and clinical data were recorded. Specific IgG was quantified and its association with predictive factors was analyzed by bivariate analysis (p<0.05). In cases with signs/symptoms associated with B19V, specific IgM and viral DNA were also determined. Results: 317 cases were studied and anti-B19V IgG was detected in 214/317 (67.5%). No association was found between seroprevalence and maternal age, multiparity, cohabitation with children under 15 years of age, or presence of maternal/fetal signs/symptoms. Ten cases (10.4%) of B19V infection were identified, all of them with anemia and one with fetal hydrops and VDRL+. Conclusion: in the population studied, B19V seroprevalence for was 67.5% and independent of the predictive factors, leaving 32.5% without evidence of exposure to the virus (susceptible to contracting the infection in the future). The detection of infection in symptomatic cases indicates the importance of investigating B19V in this group. |
| publisher |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
| publishDate |
2024 |
| url |
https://revistas.unc.edu.ar/index.php/med/article/view/44771 |
| work_keys_str_mv |
AT dicuatronestor seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT colazosalbettimariabelen seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT boggiogabrielamilcar seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT ortizemilia seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT pedrantimauro seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT oliveranicolaslionel seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT lucchinihector seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT gonzalezalicia seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT resinocarlos seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT morenolaura seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT adamomaria seroprevalenceandinfectionbyhumanparvovirusb19inpregnantwomenfromcordobaargentina20212022 AT dicuatronestor seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT colazosalbettimariabelen seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT boggiogabrielamilcar seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT ortizemilia seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT pedrantimauro seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT oliveranicolaslionel seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT lucchinihector seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT gonzalezalicia seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT resinocarlos seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT morenolaura seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT adamomaria seroprevalenciaeinfeccionporparvovirushumanob19enembarazadasdecordobaargentina20212022 AT dicuatronestor soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT colazosalbettimariabelen soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT boggiogabrielamilcar soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT ortizemilia soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT pedrantimauro soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT oliveranicolaslionel soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT lucchinihector soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT gonzalezalicia soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT resinocarlos soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT morenolaura soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 AT adamomaria soroprevalenciaeinfeccaoporparvovirushumanob19emgestantesdecordobaargentina20212022 |
| first_indexed |
2025-02-05T22:05:37Z |
| last_indexed |
2025-02-05T22:05:37Z |
| _version_ |
1823256752594878464 |
| spelling |
I10-R327-article-447712024-12-13T14:58:44Z Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022 Seroprevalencia e infección por parvovirus humano B19 en embarazadas de Córdoba, Argentina, 2021-2022 Soroprevalência e infecção por parvovírus humano B19 em gestantes de Córdoba, Argentina, 2021-2022 Dicuatro, Néstor Colazo Salbetti, María Belén Boggio, Gabriel Amilcar Ortiz, Emilia Pedranti, Mauro Olivera, Nicolás Lionel Lucchini, Héctor González, Alicia Resino, Carlos Moreno, Laura Adamo, Maria human parvovirus b19 pregnancy seroprevalence fetal hydrops anemia parvovirus B19 gestación seroprevalencia hidropesía fetal anemia parvovírus B19 gravidez soroprevalência anemia hidropisia fetal Introduction: parvovirus B19 (B19V) infection during pregnancy can be transmitted to the fetus and cause serious complications such as fetal hydrops and stillbirth. The preexistence of specific IgG prevents vertical transmission. Seroprevalence in fertile age is variable (50-70%) and depends on the region/viral circulation, in addition to factors such as maternal age and frequent exposure to children. Objectives: to determine seroprevalence for B19V in pregnant women at Hospital Universitario de Maternidad y Neonatología (HUMN), analyze its association with predictive factors and describe cases of B19V infection. Methods: observational, cross-sectional study. Patients treated at HUMN during 2021-2022 were included and compatible demographic and clinical data were recorded. Specific IgG was quantified and its association with predictive factors was analyzed by bivariate analysis (p<0.05). In cases with signs/symptoms associated with B19V, specific IgM and viral DNA were also determined. Results: 317 cases were studied and anti-B19V IgG was detected in 214/317 (67.5%). No association was found between seroprevalence and maternal age, multiparity, cohabitation with children under 15 years of age, or presence of maternal/fetal signs/symptoms. Ten cases (10.4%) of B19V infection were identified, all of them with anemia and one with fetal hydrops and VDRL+. Conclusion: in the population studied, B19V seroprevalence for was 67.5% and independent of the predictive factors, leaving 32.5% without evidence of exposure to the virus (susceptible to contracting the infection in the future). The detection of infection in symptomatic cases indicates the importance of investigating B19V in this group. Introducción: la infección por parvovirus B19 (B19V) durante el embarazo puede transmitirse al feto y ocasionar complicaciones graves como hidropesía y muerte fetal. La preexistencia de IgG específica previene la transmisión vertical. La seroprevalencia en edad fértil es variable (50-70%) y depende de la región/circulación viral, además de factores como edad materna y exposición frecuente a niños. Objetivos: determinar seroprevalencia para B19V en embarazadas del Hospital Universitario de Maternidad y Neonatología (HUMN), analizar su asociación con factores predictores y describir los casos de infección por B19V. Métodos: estudio observacional, transversal. Se incluyeron pacientes atendidas en HUMN durante 2021-2022 y se registraron datos demográficos y clínicos compatibles. Se cuantificó IgG específica y se analizó su asociación con factores predictores mediante análisis bivariado (p<0,05). En los casos con signos/síntomas asociables a B19V se determinó además IgM específica y ADN viral. Resultados: se estudiaron 317 casos y se detectó IgG anti-B19V en 214/317 (67.5%). No se encontró asociación entre seroprevalencia y edad materna, multiparidad, convivencia con menores de 15 años ni presencia de signos/síntomas maternos/fetales. Se identificaron 10 casos (10,4%) de infección por B19V, todos ellos con anemia y uno con hidropesía fetal y VDRL+. Conclusión: en la población estudiada la seroprevalencia para B19V fue 67,5% e independiente de los factores predictores, restando 32,5% sin evidencia de exposición al virus (susceptible a contraer la infección en el futuro). La detección de la infección en casos sintomáticos indica la importancia de investigar B19V en este grupo. Introdução: A infecção pelo parvovírus B19 (B19V) durante a gravidez pode ser transmitida ao feto e causar complicações graves como hidropisia e natimorto. A preexistência de IgG específica impede a transmissão vertical. A soroprevalência na idade fértil é variável (50-70%) e depende da região/circulação viral, além de fatores como idade materna e exposição frequente dos filhos. Objetivos: determinar a soroprevalência para B19V em gestantes do Hospital Universitário de Maternidade e Neonatologia (HUMN), analisar sua associação com fatores preditivos e descrever casos de infecção por B19V. Métodos: estudo observacional, transversal. Foram incluídos pacientes atendidos no HUMN durante 2021-2022 e registrados dados demográficos e clínicos compatíveis. A IgG específica foi quantificada e sua associação com fatores preditivos foi analisada por análise bivariada (p<0,05). Nos casos com sinais/sintomas associados ao B19V, também foram determinados IgM específico e DNA viral. Resultados: Foram estudados 317 casos e IgG anti-B19V foi detectado em 214/317 (67,5%). Não foi encontrada associação entre soroprevalência e idade materna, multiparidade, coabitação com menores de 15 anos ou presença de sinais/sintomas maternos/fetais. Foram identificados dez casos (10,4%) de infecção pelo B19V, todos com anemia e um com hidropisia fetal e VDRL+. Conclusão: na população estudada a soroprevalência para B19V foi de 67,5% e independente dos fatores preditivos, restando 32,5% sem evidências de exposição ao vírus (susceptíveis de contrair a infecção no futuro). A detecção da infecção em casos sintomáticos indica a importância da investigação do B19V neste grupo. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2024-12-13 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion text/html application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/44771 10.31053/1853.0605.v81.n4.44771 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 81 No. 4 (2024); 670-685 Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 81 Núm. 4 (2024); 670-685 Revista da Faculdade de Ciências Médicas de Córdoba; v. 81 n. 4 (2024); 670-685 1853-0605 0014-6722 10.31053/1853.0605.v81.n4 spa https://revistas.unc.edu.ar/index.php/med/article/view/44771/47187 https://revistas.unc.edu.ar/index.php/med/article/view/44771/47188 Derechos de autor 2024 Universidad Nacional de Córdoba https://creativecommons.org/licenses/by-nc/4.0 |